Rein Therapeutics(RNTX)
AUSTIN, TX
BiotechnologyFocus: Perpetually Active Peptides
Rein Therapeutics is a life sciences company focused on Perpetually Active Peptides.
NephrologyRespiratoryOncology
Funding Stage
PUBLIC
Employees
5000+
Open Jobs
0
Pipeline & Clinical Trials
Impact of the Routine Collection of Symptoms on Quality of Life in Dialysis Patients
Patients Reported OutcomesClinical Trials (1)
NCT05154708Impact of the Routine Collection of Symptoms on Quality of Life in Dialysis Patients
N/ADaily hemodialysis at low dialysate flow
End Stage Renal DiseaseClinical Trials (1)
NCT01845012Evaluation of Daily HemoDialysis at Low Dialysate Flow in Patients Previously Treated With Conventional Hemodialysis
N/AProteolysis
Hemodialysis PatientsClinical Trials (1)
NCT01114789Impact on the Proteolysis of Obesity in Dialysis
N/ANo systematic monitoring of symptoms
End Stage Renal DiseaseClinical Trials (1)
NCT06257134Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients.
N/AN/A
Clinical Trials (1)
NCT06219798Evaluation of a Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease
N/ACaveolin-1-Scaffolding-Protein-Derived Peptide
Idiopathic Pulmonary FibrosisClinical Trials (1)
NCT04233814Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects
Phase 1Phase 1
Clinical Trials (1)
NCT05954988A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients
Phase 1LTI-01
Pleural EffusionClinical Trials (1)
NCT04159831A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions
Phase 2Phase 2
Clinical Trials (1)
NCT06968845A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Phase 2Nivolumab
Metastatic Kidney CancerClinical Trials (1)
NCT06364631CARE1 Pragmatic Clinical Trial
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 10 clinical trials
SEC Filings: 2 available